Evidence map›Paper›PMID 34497361›Full record

ArticleModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc2021

In Response to "Reexamining the molecular findings in specialized stromal tumors of the prostate".

Andres M Acosta, Lynette M Sholl, Adrian Marino-Enriquez, Paola Dal Cin, Brendan C Dickson, Jennifer B Gordetsky, Michael R Pins, Jesse K McKenney, Christopher D Fletcher

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Andres M AcostaDepartment of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. aacosta4@bwh.harvard.edu.
Lynette M ShollDepartment of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.ORCID 0000-0002-9532-9735
Adrian Marino-EnriquezDepartment of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.ORCID 0000-0002-7680-9901
Paola Dal CinDepartment of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Brendan C DicksonDepartment of Pathology, Mount Sinai Hospital and University of Toronto, Toronto, ON, Canada.ORCID 0000-0003-2269-6216
Jennifer B GordetskyDepartment of Pathology and Microbiology, Vanderbilt University, Nashville, TN, USA.ORCID 0000-0002-0745-2160
Michael R PinsDepartment of Pathology, Advocate Lutheran General Hospital, Park Ridge, IL, USA.
Jesse K McKenneyRobert J. Tomsich Pathology & Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH, USA.
Christopher D FletcherDepartment of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Prostatic HyperplasiaProstatic NeoplasmsHumansMaleProstate

Identifiers

PMID34497361

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.